Annual Medical Spending Attributable To Obesity: Payer- And Service-Specific Estimates
Annual Medical Spending Attributable To Obesity: Payer- And Service-Specific Estimates
复制标题
DOI：
10.1377/hlthaff.28.5.w822
复制
发表时间：
2009-09-01
期刊：
影响因子：
9.7
通讯作者：
Dietz, William
中科院分区：
文献类型：
--
作者：
Finkelstein, Eric A.;Trogdon, Justin G.;Dietz, William
1998年，肥胖症的医疗费用估计高达785亿美元，其中大约一半由联邦医疗保险和医疗补助提供。这项分析按住院、非住院和处方药支出的不同类别，对美国各支付者(联邦医疗保险、医疗补助和私人保险公司)的肥胖成本进行了最新估计。我们发现，到2006年，肥胖发病率的增加导致了近400亿美元的医疗支出增加，其中包括70亿美元的医疗保险处方药成本。我们估计，到2008年，肥胖症的医疗费用可能会上升到每年1470亿美元。[卫生事务28，第5期(2009年)：w822-w831(2009年7月27日在线发布；10.1377/hlthaff.28.5.w822)]
In 1998 the medical costs of obesity were estimated to be as high as $ 78.5 billion, with roughly half financed by Medicare and Medicaid. This analysis presents updated estimates of the costs of obesity for the United States across payers (Medicare, Medicaid, and private insurers), in separate categories for inpatient, non-inpatient, and prescription drug spending. We found that the increased prevalence of obesity is responsible for almost $ 40 billion of increased medical spending through 2006, including $ 7 billion in Medicare prescription drug costs. We estimate that the medical costs of obesity could have risen to $ 147 billion per year by 2008. [Health Affairs 28, no. 5 (2009): w822-w831 (published online 27 July 2009; 10.1377/hlthaff.28.5.w822)]